Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

LYELLYEL
3 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in LYELL IMMUNOPHARMA INC

GOLDMAN SACHS GROUP INC holds 86,779 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $1.2M as of 2026-Q2. The position was decreased (-24.2% shares). LYEL represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$1.2M

Current Shares

86,779

Total Value Change

-$1.8M

Total Shares Change

-9,896

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
86,779
-24.2%
$1.2M0.0%$14.05
0
2026-Q1
Increased
114,491
+18.4%
$2.3M0.0%$23.33
31
2025-Q4
New
96,675
-
$3M0.0%$31.59
36

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used